{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:39:57Z","timestamp":1792460397136,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"DOI":"10.1007\/s10067-026-08483-3","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:20:58Z","timestamp":1792412458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased risk of cancer in patients with mixed connective tissue disease: a population-based cohort study in Korea"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9977-6444","authenticated-orcid":false,"given":"Su Jin","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6019-6912","authenticated-orcid":false,"given":"Sojeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3703-4514","authenticated-orcid":false,"given":"Minae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5767-221X","authenticated-orcid":false,"given":"Seung Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8012-7364","authenticated-orcid":false,"given":"Doo-Ho","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"8483_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.berh.2012.01.009","volume":"26","author":"OD Ortega-Hernandez","year":"2012","unstructured":"Ortega-Hernandez OD, Shoenfeld Y (2012) Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment. Best Pract Res Clin Rheumatol 26:61\u201372. https:\/\/doi.org\/10.1016\/j.berh.2012.01.009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8483_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.berh.2016.03.002","volume":"30","author":"R Gunnarsson","year":"2016","unstructured":"Gunnarsson R, Hetlevik SO, Lilleby V, Molberg \u00d8 (2016) Mixed connective tissue disease. Best Pract Res Clin Rheumatol 30:95\u2013111. https:\/\/doi.org\/10.1016\/j.berh.2016.03.002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8483_CR3","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.semarthrit.2021.09.009","volume":"51","author":"AE Clarke","year":"2021","unstructured":"Clarke AE, Pooley N, Marjenberg Z et al (2021) Risk of malignancy in patients with systemic lupus erythematosus: systematic review and meta-analysis. Semin Arthritis Rheum 51:1230\u20131241. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.09.009","journal-title":"Semin Arthritis Rheum"},{"key":"8483_CR4","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/art.37969","volume":"65","author":"A Onishi","year":"2013","unstructured":"Onishi A, Sugiyama D, Kumagai S, Morinobu A (2013) Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 65:1913\u20131921. https:\/\/doi.org\/10.1002\/art.37969","journal-title":"Arthritis Rheum"},{"key":"8483_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1203475416665601","volume":"21","author":"JK Qiang","year":"2017","unstructured":"Qiang JK, Kim WB, Baibergenova A, Alhusayen R (2017) Risk of malignancy in dermatomyositis and polymyositis. J Cutan Med Surg 21:131\u2013136. https:\/\/doi.org\/10.1177\/1203475416665601","journal-title":"J Cutan Med Surg"},{"key":"8483_CR6","doi-asserted-by":"publisher","first-page":"152678","DOI":"10.1016\/j.semarthrit.2025.152678","volume":"72s","author":"Y Tanaka","year":"2025","unstructured":"Tanaka Y (2025) Is mixed connective tissue disease (MCTD) a subtype of systemic sclerosis? Semin Arthritis Rheum 72s:152678. https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152678","journal-title":"Semin Arthritis Rheum"},{"key":"8483_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.12997\/jla.2022.11.2.103","volume":"11","author":"DS Kyoung","year":"2022","unstructured":"Kyoung DS, Kim HS (2022) Understanding and utilizing claim data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) database for research. J Lipid Atheroscler 11:103\u2013110. https:\/\/doi.org\/10.12997\/jla.2022.11.2.103","journal-title":"J Lipid Atheroscler"},{"key":"8483_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/itt.S390023","volume":"12","author":"CA Ferrara","year":"2023","unstructured":"Ferrara CA, La Rocca G, Ielo G, Libra A, Sambataro G (2023) Towards early diagnosis of mixed connective tissue disease: updated perspectives. Immunotargets Ther 12:79\u201389. https:\/\/doi.org\/10.2147\/itt.S390023","journal-title":"Immunotargets Ther"},{"key":"8483_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/joim.13752","volume":"295","author":"K Chevalier","year":"2024","unstructured":"Chevalier K, Thoreau B, Michel M et al (2024) Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: a multicenter retrospective cohort. J Intern Med 295:532\u2013543. https:\/\/doi.org\/10.1111\/joim.13752","journal-title":"J Intern Med"},{"key":"8483_CR10","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3899\/jrheum.121272","volume":"40","author":"A Hajas","year":"2013","unstructured":"Hajas A, Szodoray P, Nakken B et al (2013) Clinical course, prognosis, and causes of death in mixed connective tissue disease. J Rheumatol 40:1134\u20131142. https:\/\/doi.org\/10.3899\/jrheum.121272","journal-title":"J Rheumatol"},{"key":"8483_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13075-017-1494-7","volume":"19","author":"S Reiseter","year":"2017","unstructured":"Reiseter S, Gunnarsson R, Corander J et al (2017) Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study. Arthritis Res Ther 19:284. https:\/\/doi.org\/10.1186\/s13075-017-1494-7","journal-title":"Arthritis Res Ther"},{"key":"8483_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10165-006-0535-x","volume":"17","author":"Y Yoshidome","year":"2007","unstructured":"Yoshidome Y, Hayashi S, Maruyama Y et al (2007) A case of mixed connective tissue disease complicated with thymic carcinoma and Hashimoto\u2019s thyroiditis. Mod Rheumatol 17:63\u201366. https:\/\/doi.org\/10.1007\/s10165-006-0535-x","journal-title":"Mod Rheumatol"},{"key":"8483_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.12659\/ajcr.894176","volume":"16","author":"S Thongpooswan","year":"2015","unstructured":"Thongpooswan S, Tushabe R, Song J, Kim P, Abrudescu A (2015) Mixed connective tissue disease and papillary thyroid cancer: a case report. Am J Case Rep 16:517\u2013519. https:\/\/doi.org\/10.12659\/ajcr.894176","journal-title":"Am J Case Rep"},{"key":"8483_CR14","doi-asserted-by":"publisher","first-page":"568","DOI":"10.11405\/nisshoshi.104.568","volume":"104","author":"K Monoe","year":"2007","unstructured":"Monoe K, Kanno Y, Saito H et al (2007) A case of hepatocellar carcinoma associated with mixed connective tissue disease. Nihon Shokakibyo Gakkai Zasshi 104:568\u2013572. https:\/\/doi.org\/10.11405\/nisshoshi.104.568","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"8483_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/ms9.0000000000001462","volume":"86","author":"M Kudsi","year":"2024","unstructured":"Kudsi M, Khalayli N, Hola L, Aldeeb M, Aziz A (2024) Mixed connective tissue and ovarian cancer: a case report. Ann Med Surg (Lond) 86:467\u2013471. https:\/\/doi.org\/10.1097\/ms9.0000000000001462","journal-title":"Ann Med Surg (Lond)"},{"key":"8483_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/00000441-198510000-00003","volume":"290","author":"KR McLeish","year":"1985","unstructured":"McLeish KR, Smith MR, Gohara AF (1985) Non-Hodgkin\u2019s lymphoma and membranous nephropathy in mixed connective tissue disease. Am J Med Sci 290:152\u2013154. https:\/\/doi.org\/10.1097\/00000441-198510000-00003","journal-title":"Am J Med Sci"},{"key":"8483_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/rheumatology\/kes303","volume":"52","author":"M Bonifazi","year":"2012","unstructured":"Bonifazi M, Tramacere I, Pomponio G et al (2012) Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 52:143\u2013154. https:\/\/doi.org\/10.1093\/rheumatology\/kes303","journal-title":"Rheumatology (Oxford)"},{"key":"8483_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/rheumato4040017","volume":"4","author":"D Blachut","year":"2024","unstructured":"Blachut D, Przywara-Chowaniec B, Tomasik A (2024) Pathogenesis, epidemiology, and risk factors of malignant tumors in systemic lupus erythematosus. Rheumato 4:209\u2013221. https:\/\/doi.org\/10.3390\/rheumato4040017","journal-title":"Rheumato"},{"key":"8483_CR19","doi-asserted-by":"publisher","first-page":"102945","DOI":"10.1016\/j.critrevonc.2020.102945","volume":"150","author":"S Khanmohammadi","year":"2020","unstructured":"Khanmohammadi S, Shabani M, Tabary M, Rayzan E, Rezaei N (2020) Lymphoma in the setting of autoimmune diseases: a review of association and mechanisms. Crit Rev Oncol Hematol 150:102945. https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102945","journal-title":"Crit Rev Oncol Hematol"},{"key":"8483_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/030097401753180363","volume":"30","author":"AB Hassan","year":"2001","unstructured":"Hassan AB, Gunnarsson I, Karlsson G, Klareskog L, Forslid J, Lundberg IE (2001) Longitudinal study of interleukin-10, tumor necrosis factor-alpha, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease. Scand J Rheumatol 30:282\u2013289. https:\/\/doi.org\/10.1080\/030097401753180363","journal-title":"Scand J Rheumatol"},{"key":"8483_CR21","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1158\/1055-9965.Epi-06-0300","volume":"15","author":"KE Smedby","year":"2006","unstructured":"Smedby KE, Baecklund E, Askling J (2006) Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 15:2069\u20132077. https:\/\/doi.org\/10.1158\/1055-9965.Epi-06-0300","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"8483_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1470-2045(05)70434-4","volume":"7","author":"N Rothman","year":"2006","unstructured":"Rothman N, Skibola CF, Wang SS et al (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 7:27\u201338. https:\/\/doi.org\/10.1016\/S1470-2045(05)70434-4","journal-title":"Lancet Oncol"},{"key":"8483_CR23","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3390\/jcm9113403","volume":"9","author":"P Masciopinto","year":"2020","unstructured":"Masciopinto P, Dell\u2019Olio G, De Robertis R, Specchia G, Musto P, Albano F (2020) The role of autoimmune diseases in the prognosis of lymphoma. J Clin Med 9:3403. https:\/\/doi.org\/10.3390\/jcm9113403","journal-title":"J Clin Med"},{"key":"8483_CR24","doi-asserted-by":"publisher","first-page":"e42855","DOI":"10.1097\/md.0000000000042855","volume":"104","author":"J Duan","year":"2025","unstructured":"Duan J, Ma L, Wang T, Li T, Li Y (2025) Autoimmune diseases and diffuse large B-cell lymphoma: a Mendelian randomization study. Medicine (Baltimore) 104:e42855. https:\/\/doi.org\/10.1097\/md.0000000000042855","journal-title":"Medicine (Baltimore)"},{"key":"8483_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/2397198318766825","volume":"3","author":"L Sakr","year":"2018","unstructured":"Sakr L, Hudson M, Wang M, Younanian E, Baron M, Bernatsky S (2018) Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: longitudinal data from the Canadian Scleroderma Research Group. J Scleroderma Relat Disord 3:221\u2013227. https:\/\/doi.org\/10.1177\/2397198318766825","journal-title":"J Scleroderma Relat Disord"},{"key":"8483_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/jpm15050213","volume":"15","author":"G Castelli","year":"2025","unstructured":"Castelli G, Cocconcelli E, Grimaudo G et al (2025) Interstitial lung diseases and lung cancer: a review on similarities, common pathogenesis and therapeutic approach. J Pers Med 15:213. https:\/\/doi.org\/10.3390\/jpm15050213","journal-title":"J Pers Med"},{"key":"8483_CR27","doi-asserted-by":"publisher","first-page":"1431642","DOI":"10.3389\/fmed.2024.1431642","volume":"11","author":"P Pan","year":"2024","unstructured":"Pan P, Liu X, Wang Y, Wang H, Xu C, Lu J (2024) Unveiling the shared genes between systemic sclerosis and lung cancer. Front Med (Lausanne) 11:1431642. https:\/\/doi.org\/10.3389\/fmed.2024.1431642","journal-title":"Front Med (Lausanne)"},{"key":"8483_CR28","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.3389\/fimmu.2018.03112","volume":"9","author":"ATJ Maria","year":"2018","unstructured":"Maria ATJ, Partouche L, Goulabchand R et al (2018) Intriguing relationships between cancer and systemic sclerosis: role of the immune system and other contributors. Front Immunol 9:3112. https:\/\/doi.org\/10.3389\/fimmu.2018.03112","journal-title":"Front Immunol"},{"key":"8483_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.rdc.2020.05.005","volume":"46","author":"A Ladouceur","year":"2020","unstructured":"Ladouceur A, Tessier-Cloutier B, Clarke AE et al (2020) Cancer and systemic lupus erythematosus. Rheum Dis Clin North Am 46:533\u2013550. https:\/\/doi.org\/10.1016\/j.rdc.2020.05.005","journal-title":"Rheum Dis Clin North Am"},{"key":"8483_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","volume":"42","author":"S Bernatsky","year":"2013","unstructured":"Bernatsky S, Ramsey-Goldman R, Labrecque J et al (2013) Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun 42:130\u2013135. https:\/\/doi.org\/10.1016\/j.jaut.2012.12.009","journal-title":"J Autoimmun"},{"key":"8483_CR31","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/rheumatology\/kew215","volume":"55","author":"EH Kang","year":"2016","unstructured":"Kang EH, Lee SJ, Ascherman DP et al (2016) Temporal relationship between cancer and myositis identifies two distinctive subgroups of cancers: impact on cancer risk and survival in patients with myositis. Rheumatology (Oxford) 55:1631\u20131641. https:\/\/doi.org\/10.1093\/rheumatology\/kew215","journal-title":"Rheumatology (Oxford)"},{"key":"8483_CR32","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3390\/biomedicines13040993","volume":"13","author":"D Nemes-T\u00f6m\u00f6ri","year":"2025","unstructured":"Nemes-T\u00f6m\u00f6ri D, J\u00e1sz DK, Tari D et al (2025) Malignancy in systemic sclerosis: a multicenter retrospective study. Biomedicines 13:993. https:\/\/doi.org\/10.3390\/biomedicines13040993","journal-title":"Biomedicines"},{"key":"8483_CR33","doi-asserted-by":"publisher","first-page":"e90035","DOI":"10.1002\/acr2.90035","volume":"8","author":"DS Jalaledin","year":"2026","unstructured":"Jalaledin DS, El Kamouni H, Albert A et al (2026) Clinical associations of anti-RNPC3 autoantibodies in mixed connective tissue disease. ACR Open Rheumatol 8:e90035. https:\/\/doi.org\/10.1002\/acr2.90035","journal-title":"ACR Open Rheumatol"},{"key":"8483_CR34","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3899\/jrheum.140533","volume":"42","author":"A Hashimoto","year":"2015","unstructured":"Hashimoto A, Chiba N, Tsuno H et al (2015) Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population. J Rheumatol 42:564\u2013571. https:\/\/doi.org\/10.3899\/jrheum.140533","journal-title":"J Rheumatol"},{"key":"8483_CR35","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49:1603\u20131616. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.09.006","journal-title":"Free Radic Biol Med"},{"key":"8483_CR36","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/ph18091406","volume":"18","author":"N Rembia\u0142kowska","year":"2025","unstructured":"Rembia\u0142kowska N, Kocik Z, K\u0142osi\u0144ska A et al (2025) Inflammation-driven genomic instability: a pathway to cancer development and therapy resistance. Pharmaceuticals (Basel) 18:1406. https:\/\/doi.org\/10.3390\/ph18091406","journal-title":"Pharmaceuticals (Basel)"},{"key":"8483_CR37","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/rheumatology\/keae158","volume":"64","author":"S Izuka","year":"2025","unstructured":"Izuka S, Komai T, Itamiya T et al (2025) Machine learning-driven immunophenotypic stratification of mixed connective tissue disease, corroborating the clinical heterogeneity. Rheumatology (Oxford) 64:1409\u20131416. https:\/\/doi.org\/10.1093\/rheumatology\/keae158","journal-title":"Rheumatology (Oxford)"},{"key":"8483_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/imr.13272","volume":"321","author":"P Holicek","year":"2024","unstructured":"Holicek P, Guilbaud E, Klapp V et al (2024) Type I interferon and cancer. Immunol Rev 321:115\u2013127. https:\/\/doi.org\/10.1111\/imr.13272","journal-title":"Immunol Rev"},{"key":"8483_CR39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/bor.0000000000000755","volume":"32","author":"K Morrisroe","year":"2020","unstructured":"Morrisroe K, Nikpour M (2020) Cancer and scleroderma: recent insights. Curr Opin Rheumatol 32:479\u2013487. https:\/\/doi.org\/10.1097\/bor.0000000000000755","journal-title":"Curr Opin Rheumatol"},{"key":"8483_CR40","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/acr.24076","volume":"72","author":"K Morrisroe","year":"2020","unstructured":"Morrisroe K, Hansen D, Huq M et al (2020) Incidence, risk factors, and outcomes of cancer in systemic sclerosis. Arthritis Care Res (Hoboken) 72:1625\u20131635. https:\/\/doi.org\/10.1002\/acr.24076","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8483_CR41","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1093\/rheumatology\/keab735","volume":"61","author":"S Hoa","year":"2022","unstructured":"Hoa S, Lazizi S, Baron M et al (2022) Association between autoantibodies in systemic sclerosis and cancer in a national registry. Rheumatology (Oxford) 61:2905\u20132914. https:\/\/doi.org\/10.1093\/rheumatology\/keab735","journal-title":"Rheumatology (Oxford)"},{"key":"8483_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/art.42663","volume":"76","author":"JS Kim","year":"2024","unstructured":"Kim JS, Woods A, Gutierrez-Alamillo L et al (2024) Distinct scleroderma autoantibody profiles stratify patients for cancer risk at scleroderma onset and during the disease course. Arthritis Rheumatol 76:68\u201377. https:\/\/doi.org\/10.1002\/art.42663","journal-title":"Arthritis Rheumatol"},{"key":"8483_CR43","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41584-023-01045-w","volume":"19","author":"AGS Oldroyd","year":"2023","unstructured":"Oldroyd AGS, Callen JP, Chinoy H et al (2023) International guideline for idiopathic inflammatory myopathy-associated cancer screening: an international myositis assessment and clinical studies group (IMACS) initiative. Nat Rev Rheumatol 19:805\u2013817. https:\/\/doi.org\/10.1038\/s41584-023-01045-w","journal-title":"Nat Rev Rheumatol"},{"key":"8483_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.autrev.2006.08.007","volume":"6","author":"MP Keith","year":"2007","unstructured":"Keith MP, Moratz C, Tsokos GC (2007) Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease. Autoimmun Rev 6:232\u2013236. https:\/\/doi.org\/10.1016\/j.autrev.2006.08.007","journal-title":"Autoimmun Rev"},{"key":"8483_CR45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.05.002","volume":"127","author":"A Vlagea","year":"2018","unstructured":"Vlagea A, Falagan S, Guti\u00e9rrez-Guti\u00e9rrez G et al (2018) Antinuclear antibodies and cancer: a literature review. Crit Rev Oncol Hematol 127:42\u201349. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.05.002","journal-title":"Crit Rev Oncol Hematol"},{"key":"8483_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13075-020-02403-9","volume":"23","author":"B Stypi\u0144ska","year":"2021","unstructured":"Stypi\u0144ska B, Lewandowska A, Felis-Giemza A, Olesi\u0144ska M, Paradowska-Gorycka A (2021) Association study between immune-related miRNAs and mixed connective tissue disease. Arthritis Res Ther 23:19. https:\/\/doi.org\/10.1186\/s13075-020-02403-9","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08483-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08483-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08483-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:03:18Z","timestamp":1792458198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08483-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":46,"alternative-id":["8483"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08483-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"6 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The Institutional Review Board of Ulsan University Hospital, Ulsan, South Korea approved the study (IRB number: 2023-03-030).","order":1,"name":"Ethics","label":"Ethical considerations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}